China's Biggest Memory Chip Stock Is Almost as Good as Micron

CXMT’s DRAM IPO in July raised $8.6B and rapidly pushed its valuation to ~$487B (466% jump on debut), with H1 2026 results showing revenue +874% YoY to 150.3B yuan ($22.4B) and net profit of 77.6B yuan ($11.5B). The article argues CXMT’s expanding profitability and projected DRAM share (11% now vs 25% for Micron; estimate to 15% by 2030) could pressure Micron’s margins, especially as CXMT plans stacked DRAM production for HBM from end-2026—critical for AI. Micron shares fell 9% on the IPO day and another 10% the next day, reinforcing the near-term competitive risk.

Analysis

CXMT is a pricing threat before it is a technology threat. Over the next 1-2 quarters, the market should care more about DRAM ASP pressure in lower-end and mobile/server bins than about any immediate HBM displacement, because the fastest way for a state-backed entrant to take share is to undercut on commodity output and force incumbents to defend utilization. That typically shows up first in Micron’s mix and gross margin, not in an obvious revenue cliff, which is why the equity can rerate down faster than the earnings stream changes.

The more important second-order effect is that a China-backed supplier can shorten the memory cycle by preventing the usual price recovery after capacity discipline. SK Hynix is relatively better insulated near term because HBM remains a qualification-and-packaging game, but Micron is exposed to both lower-end share loss and a later HBM margin fight if CXMT’s roadmap keeps closing the gap. The consensus is probably too bearish on the long-dated HBM threat and too complacent about near-term DRAM pricing leakage; the bear case is falsified if MU can hold gross margin guidance and management signals no meaningful deterioration in spot/contract pricing over the next two earnings calls.

Key Decisions for Investors

• Tactically fade MU rallies: initiate a 3-6 month put spread only if Micron reclaims prior highs without a corresponding raise in gross margin guide; target a 15-25% downside move if DRAM pricing rolls over, and cut if management reiterates stable pricing or raises HBM mix assumptions.
• Pair trade: long SKHY / short MU for a 6-12 month horizon to express the view that HBM leaders defend premium pricing longer than commodity DRAM names; stop out if Micron’s HBM commentary improves materially or if SKHY loses share in AI packaging discussions.
• Set a watch item on MU for the next two earnings prints: any 100-200 bps gross margin miss or softer DRAM contract pricing is the cleanest catalyst for a short; absent that, this is more of a structural overhang than an immediate trade.
• Do not chase a long CXMT-related hedge in NVDA yet; the HBM benefit is too remote and dependent on quality qualification. Revisit only if CXMT demonstrates multi-quarter yield improvement and export restrictions do not block tool access.